• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

The Influenza Vaccine Is The Fastest Growing In The Adult Vaccine Segment Followed By The Hepatitis Vaccine

Posted on: Friday, 28 March 2008, 06:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c86970) has announced the addition of "Vaccines Report" to their offering.

Vaccine manufacturers from all over the world have been involved in a stalemate with governments regarding supply and demand. While governments are reluctant to ensure steady demand for vaccines unless the manufacturers can prove their ability to increase their supply, the latter are apprehensive about increasing production without a guarantee of sustained demand from the governments. Meanwhile, developing nations are increasingly demanding vaccines that are no longer included in the immunization schedules of developed countries. These vaccines will have to be provided at very low costs, which will not be feasible unless the demand can compensate for the low margins. Global vaccines market is estimated at USD10 billion in 2007; human vaccine valued at USD8.3 billion contributes major share ie 83% of the total market and rest 17% is occupied by animal vaccine valued at USD1.7 billion. The US is the leading market, accounting for more than 50% of the global vaccine market. Influenza vaccine is the fastest growing in the adult vaccine segment followed by Hepatitis vaccines. The vaccines market in India in 2006-07 was INR30.53 billion registering a 30.41% growth over the previous year. India's huge population makes it among the world's largest market for vaccines of all types. India faces a growing demand for new generation and 'combination' vaccines, such as DPT with Hepatitis B, Hepatitis A and Injectable polio vaccine, besides several veterinary and poultry vaccines. Indian vaccines market is dominated by paediatric vaccine with 60% of market share. Combination vaccines are driving the growth of vaccine market in India.

'Industry Insight - Vaccines' report is prepared keeping in mind the current growth in demand for vaccines in India. The report attempts to cover the industry with a perspective of global vaccines market, segments and its growth in demand.

- A market assessment of vaccines segment with reference to the market size and market trend is presented.

- Vaccines report presents the growth drivers such as increasing population, disease awareness etc.

- It presents the issues and challenges involved in vaccines with reference to vaccine funding, timely regulatory clearance.

- It provides information on the critical success factors such as pricing, government programmes etc.

- 10 Major players have been profiled providing introduction, financial, operational details of the company.

- The report presents a brief outlook about the regulatory issues and also the regulatory aspects involved in vaccines segment.

- The report provides a future outlook of vaccines market."

Topics Covered:

1. Introduction.

2. Market Overview

3. Growth Drivers

4. Issues And Challenges

5. Critical Success Factors

6. MAJOR PLAYERS

7. Regulatory Environment

8. Future Outlook

Companies Mentioned:

- Serum Institute of India Ltd

- Panacea Biotech Ltd

- Venkateshwara Hatcheries Private Ltd

- Indian Immunological Ltd

- GlaxoSmithKline Pharmaceuticals Ltd

- Aventis Pharma Limited

- Shantha Biotechnics

- Eli Lilly India

- Haffkine BioPharmaceutical Corporation Ltd (HBCL)

- Intervet India

For more information, visit http://www.researchandmarkets.com/reports/c86970

Source: Business Wire

More News in this Category